glp-1 smoking cessation was approved as a weight loss drug. Nobody told you it might also be killing your addictions. Friends and people I know on GLP-1s have been reporting an entire stream of GLP-1 receptor agonists for smoking

Learn about addiction risks and options for help.

Longitudinal Targeted Minimum Loss-based Estimation, a method that adjusts for both baseline and time-varying confounding, was used to estimate absolute risks of cardiovascular outcomes under sustained use of GLP1-RA and DPP 4i (active comparator), adjusting for baseline and time-varying confounding

This Phase 1 trial, completed on an accelerated timeline, marks a key milestone in validating both the safety and translational potential of Hanmis next generation triple agonist in humans.Based on these results, Hanmi plans to initiate Phase 2 clinical trials in the second half of 2025, evaluating the long-term effects of HM15275 in reducing body weight and preserving lean mass in patients with severe obesity

Clinically Backed Probiotic Always Alive: This advanced probiotic arrives alive and activates within hours in your small intestine where 90% of nutrient absorption occurs, fostering balanced gut health and supporting regularity for optimal daily comfort

Unlike injectable medications or stimulant-based appetite suppressants, GLP-1 Formula supports the bodys natural GLP-1 response using carefully selected, research-supported ingredients